PD-1 expression by monocytes is reportedly increased in human chronic lymphocytic leukemia (25), HIV or active tuberculosis (22, 24), and sepsis (23), whereas PD-1/PD-L1 blockade restores innate responses in sepsis (23, 44, 45). The gene discussed is PDCD1; the disease is tuberculosis.